newsfilter
← Latest News
GlobeNewswire·

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments

NEWPORT BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc.'s (NASDAQ:ELAB) ("PMGC," "we," or "our") wholly owned subsidiary, NorthStrive Biosciences Inc. ("Northstrive Biosciences"), announced today a